Biogen reported $42.62B in Market Capitalization for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 190.99B 1.86B
Acadia Pharmaceuticals ACAD:US $ 4.13B 4.37B
Acorda Therapeutics ACOR:US $ 46.22M 13.12M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
ALKERMES ALKS:US 2.97B 200.47M
Amgen AMGN:US $ 143.27B 9.41B
Bayer BAYN:GR 47.31B 5.06B
Biogen BIIB:US $ 42.62B 4.94B
Biomarin Pharmaceutical BMRN:US $ 13.79B 2.12B
Bluebird Bio BLUE:US $ 2.02B 847.67M
Bristol Myers Squibb BMY:US $ 141.03B 855.48M
Eli Lilly And LLY:US $ 179.16B 17.65B
Esperion Therapeutics ESPR:US $ 789.78M 64.98M
Gilead Sciences GILD:US $ 81.37B 8.34B
Gw Pharmaceuticals GWPH:US 6.84B 3.24B
Intercept Pharmaceuticals ICPT:US $ 762M 53.49M
Intra Cellular Therapies ITCI:US $ 2.56B 502.26M
Marinus Pharmaceuticals MRNS:US $ 434.02M 41.13M
Merk MRK:US $ 195137.94M 11818.88M
Moderna Inc MRNA:US $ 52.4B 11.06B
Neurocrine Biosciences NBIX:US $ 9.19B 238.42M
Novartis NOVN:VX 199.26B 7.11B
Pfizer PFE:US $ 202096.88M 2565.35M
Ptc Therapeutics PTCT:US $ 3.33B 834.67M
Puma Biotechnology PBYI:US $ 391.31M 16.65M
Regeneron Pharmaceuticals REGN:US $ 50.69B 862.48M
Sangamo Biosciences SGMO:US $ 1.8B 406.46M
Sanofi SNY:US 124.4B 3.39B
Sanofi SAN:FP 106.07B 6.99B
Sarepta Therapeutics SRPT:US $ 5.92B 7.53B
Seattle Genetics SGEN:US $ 25.18B 6.4B
Teva Pharmaceutical TEVA:IT 41.88B 8.4B
Ultragenyx Pharmaceutical RARE:US $ 7.62B 1.5B
United Therapeutics UTHR:US $ 7.49B 740.61M
Vertex Pharmaceuticals VRTX:US $ 55.62B 5.84B
YTE INCY:US $ 17.87B 1.18B